Safety Study of BIIB033 in Subjects With Multiple Sclerosis

Clinical trial NCT01244139 · COMPLETED

Trial details

NCT number: NCT01244139
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsing-Remitting Multiple Sclerosis Multiple Sclerosis

Start date: 2010-10-01
Primary completion: 2012-04-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.